Synteract focusing on specific therapeutic areas as it eyes market growth

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/showcake)
(Image: iStock/showcake)
The contract research organization (CRO) Synteract today announced the creation of “therapeutic centers of development” as it looks to deepen its footprint in the mid-size CRO market space.

According to the company, the centers of development will include oncology – especially immunotherapy studies – pediatrics, neuro-degenerative disorders, as well as rare and orphan diseases.

"Our centers of therapeutic development are areas of specific focus where we have a lot of experience,"​ Synteract CEO Steve Powell told us. 

The CRO will continue to support other therapeutic areas where clients have needs, he explained; "However, by more clearly defining our areas of ​specialization we have an opportunity to make it easier to answer 'Why Synteract?'"

Echoing this sentiment in the press release, chief commercial officer Jack Shannon said that by “more clearly delineating”​ the company’s attention on “these growing development areas”​ it will have “a real opportunity”​ to expand its presence in the mid-market space​.

The new position was created in collaboration with its customers and internal teams, according to the company. 

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers